TrialScope Expands Leadership Team with New Chief Commercial Officer

by Darcy Grabenstein   Contributor

Disclaimer: All opinions expressed by Contributors are their own and do not represent those of their employers, or
Contributors are fully responsible for assuring they own any required copyright for any content they submit to This website and its owners shall not be liable for neither information and content submitted for publication by Contributors, nor its accuracy.

   726    Comments 0

Chris Venezia to Leverage His Expertise in Healthcare Technology

TrialScope, the global leader in clinical trial transparency, has hired Chris Venezia as Chief Commercial Officer, expanding its executive team.

Much of Venezia’s career has been focused on pharmaceutical and healthcare technologies. A frequent speaker and trainer, he served as Chief Revenue Officer of Signals Analytics. Prior to that, he worked in global sales at both Clarivate Analytics and Thomson Reuters, and served as vice president of sales at GlobalData Plc.

Venezia’s previous roles supported technologies leveraging the power of data, making him the perfect fit for the role. TrialScope’s products and services enable customers ensure disclosure compliance, maximize trial transparency, improve patient engagement and accelerate study recruitment.
He said that the company’s stellar reputation, world-class products and potential for growth were reasons he decided to join the TrialScope team. Venezia expressed excitement about rallying the entire company united around “one vision and one voice.”

“COVID-19 has shined a bright spotlight on the importance of speed and innovation in the drug development process,” said Venezia. “To deliver safe and effective treatments, pharmaceutical companies require patients who trust the clinical trial journey and believe in the treatment’s potential. Accelerating that patient journey will directly lead to novel breakthroughs, and transparency of trial information is where it all starts. That’s why joining TrialScope was an easy decision for me.”

“We are excited to add someone of Chris’s caliber to our team,” said TrialScope CEO Jeff Kozloff. “With his guidance, we will continue to ensure our sponsors are compliant with global disclosure regulations and give their trial data superpowers throughout the lifecycle of the trial and across the organization.”

Looking toward the future, Venezia predicts clinical trial transparency will be one of the most important factors in advancing medical science. A big part of that, he adds, is connecting more patients with clinical research.

“TrialScope will be that bridge.”

About TrialScope
TrialScope unlocks clinical trial data superpowers. The TrialScope Transparency CloudTM makes centralizing, structuring and activating clinical trial information simple, for use across the organization and at every stage of the study. Our integrated platform is used by 16 of the top 20 clinical trial sponsors in the world, who rely on TrialScope to ensure disclosure compliance, maximize trial transparency, improve patient engagement and accelerate study recruitment. To learn more, visit


Subscribe to Newsletter
Share this:              


There are no comments yet. You can be the first.

Leave a Reply

Your email address will not be published. Required fields are marked *